11 min listen
Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy
Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy
ratings:
Length:
12 minutes
Released:
Jan 27, 2022
Format:
Podcast episode
Description
The double-blind, randomized phase III EMPEROR-Preserved trial showed a benefit of the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with preserved ejection fraction (HFpEF). Now let us dig a bit more into those headlines.
Released:
Jan 27, 2022
Format:
Podcast episode
Titles in the series (100)
MRSA - The basics about Methicillin Resistant Staphylococcal Aureus: Resistance and virulence mechanisms are discussed. Clinical presentations as well as the difference between colonization and infection are considered.Screening, prevention, and understanding Community Acquired MRSA vs Healthcare Acquired MRSA strains ca... by Hospital and Internal Medicine Podcast